153037-40-2

Basic information

• Product Name: 1426129-50-1 enantioMer
• Synonyms: 1426129-50-1 enantioMer;(S)-tert-butyl (1-([1,1'-biphenyl]-4-yl)-3-hydroxypropan-2-yl)carbaMate;(2S)-2-(tert-Butoxycarbonylamino)-3-(biphenyl-4-yl)propanol;Carbamic acid, N-[(1S)-2-[1,1'-biphenyl]-4-yl-1-(hydroxymethyl)ethyl]-, 1,1-dimethylethyl ester
• CAS NO: 153037-40-2
• Molecular Formula: C₂₀H₂₅NO₃
• Molecular Weight: 327.4174
• EINECS: -0
• Mol File: 153037-40-2.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 1426129-50-1 enantioMer(CAS DataBase Reference)
• NIST Chemistry Reference: 1426129-50-1 enantioMer(153037-40-2)
• EPA Substance Registry System: 1426129-50-1 enantioMer(153037-40-2)

Safety Data

• Hazardous Substances Data: 153037-40-2(Hazardous Substances Data)

Usage

General Description

1426129-50-1 enantioMer is a chemical compound that exists as an enantiomer, which means it has two mirror-image forms that are non-superimposable. It is commonly used in the pharmaceutical industry for the synthesis of chiral molecules and drugs. Enantiomers have different biological activities and pharmacological properties, making them important in drug development and research. This specific chemical has a unique molecular structure that makes it useful for various applications in chemistry and medicine. Its enantiomeric form is important for understanding its properties and potential uses in different sectors. Overall, 1426129-50-1 enantioMer is a significant chemical compound with diverse potential applications in the field of pharmaceuticals and beyond.

Upstream product

• 119273-61-9 N-tert-butoxycarbonyl-p-phenyl-L-phenylalanine 
• 543-27-1 isobutyl chloroformate 
• 24424-99-5 di-tert-butyl dicarbonate 
• 109-02-4 4-methyl-morpholine 

Relevant articles and documents

A kind of the heart fades the medicine Entresto key intermediate (R)- tert-butyl (1 - ([1, 1' - biphenyl] - 4 - yl) - 3 - hydroxy - 2 - yl) carbamate preparation method

The invention relates to a preparation method of a drug key intermediate, particularly a method for preparing (R)-tert-butyl-(1-([1,1'-biphenyl]-4-yl)-3-hydroxypropane-2-yl)carbamate by chiral resolution. The method has the advantages of cheap and accessible raw materials, low production cost, high separation yield and high chiral purity of the product, and is simple to operate, friendly to the environment and suitable for industrial production.

PHOSPHONO SUBSTITUTED TETRAZOLE DERIVATIVES AS ECE INHIBITORS

The present invention relates to the N-phosphonomethyl substituted compounds of formula STR1